Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Not passing the North American Pharmacy Licensure Examination (NAPLEX) is the reality for a significant number of PharmD graduates. The average first time pass rates for the NAPLEX have experienced significant drops since 2017, hitting an all-time low (76.6 %) for the Class of 2023. While most candidates eventually pass the NAPLEX, a staggering 3228 PharmD graduates remain unlicensed due to unsuccessful licensure examinations from cycle years 2022 to 2024. Further decline is anticipated with impending changes to the structure of the NAPLEX in 2025. Unfortunately, unlicensed graduates are unable to practice and earn pharmacist salaries, leaving them with significant student debt. This commentary, examines the key drivers of this problem and suggests pragmatic measures to support the success of graduates who have not yet passed NAPLEX.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cptl.2025.102327 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Physician Assistant Education Association End of Curriculum Exam as a Predictor for Physician Assistant National Certifying Examination Performance.
J Physician Assist Educ
September 2025
Rachel Ditoro, EdD, MSPAS, PA-C, is a professor, program director of Salus at Drexel University PA Program, at Drexel University, Elkins Park, Pennsylvania.
Introduction: Physician assistant programs use summative evaluations to assess near graduates, with many using the PA Education Association (PAEA) End of Curriculum (EOC) exam to assess the medical knowledge component. Accurate identification of those students at risk of low Physician Assistant National Certifying Examination (PANCE) performance is imperative. The purpose of this study was to evaluate the relationship between the outcomes of the PAEA EOC exam and the PANCE.
View Article and Find Full Text PDFCultivating Talent from Within: Exploring pharmacy technician interest in pursuing a PharmD.
J Am Pharm Assoc (2003)
August 2025
Learning and Development, Walgreen Co., Deerfield, IL.
Background: The pharmacy profession continues to face a shortage of pharmacists, exacerbated by declining pharmacy school graduates, increasing prescription volume, and increased demand for other pharmacy services. The pharmacy technician population works side by side pharmacists every day and represent potential candidates for future pharmacists.
Objectives: To assess community pharmacy technicians' interest in pursuing a PharmD degree and to identify the barriers preventing them from completing their prepharmacy requirements.
Prematriculation Programs for Student Pharmacist Success.
Am J Pharm Educ
August 2025
Texas Tech University, Health Sciences Center, Jerry H. Hodge School of Pharmacy, Lubbock, TX, USA.
Objective: To characterize prematriculation programs among US colleges/schools of pharmacy and explore their impact on improving student success among PharmD students.
Methods: A national survey was conducted by the 2022-2023 American Association of Colleges of Pharmacy Student Affairs Committee to investigate student success among American Association of Colleges of Pharmacy member institutions. The survey collected demographic data and information on prematriculation offerings, delivery, goals, and impact.
Strategies for Effectuating Learner Readiness for COEPA through Enhanced Integration of Foundational and Clinical Sciences.
Am J Pharm Educ
July 2025
College of Pharmacy, Roseman University of Health Sciences, 11 Sunset Way, Henderson, NV 89014. Electronic address:
Objective: This article aims to provide a framework for seamlessly integrating COEPA's Domain 1 (knowledge) within the pharmacy curriculum.
Findings: Since the 1990s, pharmacy education in the United States has transitioned, from a primarily didactic and research-focused model to one centered on patient care, and clinical decision-making. This evolution, driven by shifts in healthcare practice,public, expectations, professional standards, and accreditation requirements, demands, that entry-level pharmacy graduates integrate foundational and clinical sciences alongside essential soft skills.
Effectiveness, Tolerance, and Safety of Meropenem in a Pediatric Outpatient Parenteral Antimicrobial Therapy Program.
Can J Hosp Pharm
July 2025
, MD, is with the Division of Infectious Diseases, Department of Pediatrics, CHU Sainte-Justine and Université de Montréal, Montréal, Quebec.
Background: Outpatient parenteral antimicrobial therapy (OPAT) is often used for patients who need long-term antimicrobial therapy. Meropenem is a broad-spectrum antibiotic used to treat polymicrobial and multidrug-resistant bacterial infections.
Objective: To evaluate the efficacy, tolerance, and safety of IV meropenem for pediatric patients in the OPAT program at CHU Sainte-Justine in Montréal, Quebec.